Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 5 | |
Outperform | 1 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in EUR
The 6 analysts offering 12 month price targets for Maat Pharma SA have a median target of 15.10, with a high estimate of 16.00 and a low estimate of 13.80. The median estimate represents a 106.85% increase from the last price of 7.30.
High | 119.2% | 16.00 |
Med | 106.8% | 15.10 |
Low | 89.0% | 13.80 |
Earnings history & estimates in EUR
Average growth rate | +20.37% |
More ▼
Revenue history & estimates in EUR
Average growth rate | +51.46% |
More ▼